Content about Imatinib

April 2, 2013
Reports: Indian Supreme Court strikes down leukemia drug patent

A ruling by India's high court means cheaper generic versions of a cancer drug will remain available in developing countries, according to published reports.

February 25, 2013
FDA approves Bayer's Stivarga for gastrointestinal stromal tumors

The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

January 25, 2013
FDA approves Gleevec for most common pediatric cancer

The Food and Drug Administration has approved a Novartis drug for treating leukemia in children.

June 4, 2012
Bayer gastrointestinal cancer drug extends progression-free survival in trial

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

March 16, 2012
Patients taking oral cancer drugs may risk drug interactions, study finds

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

February 1, 2012
FDA approves new indication for Novartis' Gleevec

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

December 20, 2011
Apothecary Shops distributes GlowCap in pilot program

Specialty pharmacy provider The Apothecary Shops is encouraging medication adherence with a cap for pill containers that cues patients with lights and sounds, the company said.

May 23, 2011
Sutent OKed as pancreatic NET treatment

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

May 18, 2011
Medco: Cancer drugs to see huge rise by 2013

Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

October 27, 2010
FDA OKs expanded use of Sprycel

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

July 18, 2010
Reporters Notebook

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

July 15, 2010
Novartis reports positive Q2

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 11, 2010
Sprycel receives priority review from FDA

A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...

June 17, 2010
Novartis’ Tasigna receives nod from FDA

The Food and Drug Administration has approved a drug as an early treatment for a...

March 11, 2010
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

February 18, 2010
Novartis' Tasigna receives priority review from FDA

The Food and Drug Administration will shorten its review time of a Novartis drug under...

© 2013 Drug Store News. All Rights Reserved.